Drug Shortage Report for TADALAFIL

Last updated on 2020-04-03 History
Report ID 95241
Drug Identification Number 02455366
Brand name TADALAFIL
Common or Proper name TADALAFIL
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-10-02
Estimated end date 2020-04-02
Actual end date 2020-04-02
Shortage status Resolved
Updated date 2020-04-03
Company comments
Health Canada comments
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-10-02 English Compare
v2 2019-10-02 French Compare
v3 2019-10-02 English Compare
v4 2019-10-02 French Compare
v5 2019-10-03 English Compare
v6 2019-12-04 English Compare
v7 2019-12-04 French Compare
v8 2020-01-14 English Compare
v9 2020-01-14 French Compare
v10 2020-01-28 English Compare
v11 2020-01-28 French Compare
v12 2020-02-03 English Compare
v13 2020-02-03 French Compare
v14 2020-02-12 English Compare
v15 2020-02-12 French Compare
v16 2020-04-03 English Compare
v17 2020-04-03 French Compare
v18 2020-04-03 English Compare
v19 2020-04-03 French Compare